Otitic hydrocephalus.
Commins
D J
DJ
Department of Otolaryngology, Radcliffe Infirmary, Oxford, England.
Koay
B
B
Milford
C A
CA
Renowden
S
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D006801:Humans; D006849:Hydrocephalus / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D008297:Male; D008416:Mastoid / Q000601:surgery; D008795:Metronidazole / Q000627:therapeutic use; D010035:Otitis Media, Suppurative / Q000150:complications* / Q000188:drug therapy; D012851:Sinus Thrombosis, Intracranial / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D000994:Antitrichomonal Agents; D002511:Cephalosporins; D008795:Metronidazole; D002439:Cefotaxime